AI Diagnostics Push: Recent chatter on social media has centered around Zoetis Inc.'s advancements in AI and machine learning for veterinary diagnostics. Many users are intrigued by how this could position the company as a leader in animal health amid growing concerns over zoonotic diseases. The discussion reflects curiosity about the potential impact on future growth.
Stock Price Concerns: Another focal point online is the recent dip in Zoetis's stock price, with some attributing it to weaker sales of a key drug for pet arthritis pain. Several voices suggest the selloff might be excessive, hinting at a possible recovery. This has sparked debates over the stock's current valuation and long-term prospects.
Market Leadership: There’s also buzz about Zoetis being the global leader in pet health, with comments on its strong market share and upcoming drug launches. Users are highlighting the company’s solid fundamentals despite last year’s stock decline. The tone here leans toward optimism for its strategic positioning.
Note: This discussion summary was generated from an AI condensation of post data.
Zoetis Inc. Revenue
Zoetis Inc. had revenues of $2.4B in Q3 2025. This is an increase of 0.5% from the same period in the prior year.
You can track ZTS financials on Quiver Quantitative's ZTS stock page.
Zoetis Inc. Congressional Stock Trading
Members of Congress have traded $ZTS stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ZTS stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 12/19, 11/18 and 1 sale worth up to $15,000 on 08/05.
- SENATOR MARKWAYNE MULLIN sold up to $50,000 on 11/10.
- REPRESENTATIVE RICK LARSEN sold up to $15,000 on 10/06.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/22 and 1 sale worth up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Zoetis Inc. Hedge Fund Activity
We have seen 694 institutional investors add shares of Zoetis Inc. stock to their portfolio, and 1,009 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,833,796 shares (+54.8%) to their portfolio in Q3 2025, for an estimated $414,641,030
- DIAMOND HILL CAPITAL MANAGEMENT INC added 2,692,799 shares (+inf%) to their portfolio in Q3 2025, for an estimated $394,010,349
- NORDEA INVESTMENT MANAGEMENT AB added 2,179,578 shares (+79.2%) to their portfolio in Q4 2025, for an estimated $274,234,503
- CORIENT PRIVATE WEALTH LLC removed 1,534,666 shares (-59.5%) from their portfolio in Q3 2025, for an estimated $224,552,329
- VICTORY CAPITAL MANAGEMENT INC removed 1,382,837 shares (-88.1%) from their portfolio in Q3 2025, for an estimated $202,336,709
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,227,085 shares (+83.4%) to their portfolio in Q3 2025, for an estimated $179,547,077
- BANK OF NEW YORK MELLON CORP removed 1,196,514 shares (-24.3%) from their portfolio in Q3 2025, for an estimated $175,073,928
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Zoetis Inc. Government Contracts
We have seen $553,520 of award payments to $ZTS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- THIS IS A DELIVERY ORDER FOR WIRE TIES FOR THE USDA, AMS, COTTON AND TOBACCO PROGRAM; THIS IS THE FIRST DEL...: $503,000
- NM - NEW MEXICO ESFO - CHEMICAL IMMOBILIZATION DRUG (TELAZOL) FOR MEXICAN WOLF RECOVERY PROGRAM: $35,520
- RABIES VACCINES FOR OEHE WITH BASE AND FOUR OPTIONS: $15,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Zoetis Inc. Analyst Ratings
Wall Street analysts have issued reports on $ZTS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 11/12/2025
- Morgan Stanley issued a "Overweight" rating on 11/10/2025
- Argus Research issued a "Buy" rating on 09/09/2025
- Piper Sandler issued a "Overweight" rating on 08/11/2025
To track analyst ratings and price targets for Zoetis Inc., check out Quiver Quantitative's $ZTS forecast page.
Zoetis Inc. Price Targets
Multiple analysts have issued price targets for $ZTS recently. We have seen 8 analysts offer price targets for $ZTS in the last 6 months, with a median target of $167.5.
Here are some recent targets:
- Glen Santangelo from Barclays set a target price of $136.0 on 12/09/2025
- Mark Massaro from BTIG set a target price of $160.0 on 12/03/2025
- Jonathan Block from Stifel set a target price of $130.0 on 11/18/2025
- Erin Wright from Morgan Stanley set a target price of $175.0 on 11/10/2025
- Chris Schott from JP Morgan set a target price of $200.0 on 11/05/2025
- Andrea Alfonso from UBS set a target price of $141.0 on 11/05/2025
- Jasper Hellweg from Argus Research set a target price of $190.0 on 09/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
